Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton
Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416)
10/2008
10/23/2008US20080261981 3-{4-[4-(2-amino-3-morpholin-4-yl-3-oxo-propyl)-phenoxy]-phenyl}-N-hydroxypropionamide hydrochloride; for reducing blood glucose, free fatty acids, cholesterol, triglycerides levels
10/23/2008US20080261949 ethyl 4-[4-(2-hydroxy-3-(4-hydroxy-3-(methylsulphonylamino)phenoxy)propylamino)cyclohexyl]benzoic acid; beta-3 adrenergic receptor agonist; tocolytics; delaying preterm birth; antidiabetic; obesity; oxyalkylation of the phenyl(alkyl)cyclohexyl(alkyl)amine with a glycidyl ether
10/22/2008CN101291665A Naphthyl derivatives as inhibitors of beta-amyloid aggregation
10/22/2008CN101289412A Method for preparing chelates of zinc threonine
10/22/2008CN101289411A Method for preparing zinc threonine
10/22/2008CN101289410A Method for preparing D-phenylalanine
10/22/2008CN101289409A Process for preparing 11-aminoundecanoic acid by ammoniation catalysis method
10/22/2008CN100427460C Method for synthesis of L-norvaline
10/22/2008CN100427457C Method for preparing p-aminobenzoic acid
10/22/2008CN100427454C Method for producing difluoro-acetyl-acetic acid alkylesters
10/21/2008US7439396 Pharmaceutical/cosmetic compositions comprising novel ligands that activate RAR receptors
10/21/2008US7439390 Reacting aldehyde with amide, carbon monoxide and hydrogen in amidocarbonylation reaction to give N-acyl amino acid in presence of cobalt carbonyl catalyst, precipitating Co(N-acyl-amino acid)2 by feeding oxygen into mixture, separating Co(N-acyl-amino acid)2, hydrolyzing residue to obtain amino acid
10/21/2008US7439387 Process for the preparation of Gabapentin form-II
10/21/2008US7439383 Sodium channel blockers
10/21/2008US7439368 Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative
10/21/2008US7439342 Thrombopoietin mimetics
10/16/2008WO2008124097A2 Salts of isophosphoramide mustard and analogs thereof
10/16/2008WO2008122620A1 Iso ca-4 and analogues thereof as potent cytotoxic agents inhibiting tubuline polymerisation
10/16/2008WO2008122504A1 Alpha-hydroxyketones
10/16/2008US20080255499 Using alpha ketoamino acid; tissue toxicity; urogenital disorders
10/16/2008US20080255369 Synthesis of Renin Inhibitors Involving a Cycloaddition Reaction
10/16/2008US20080255367 Process for the preparation and isolation of the individual stereoisomers of 1-amino, 3-substituted phenylcyclopentane-carboxylates
10/16/2008US20080255250 Compounds and Compositions for Delivering Active Agents
10/16/2008US20080255232 Naphthyl Derivatives as Inhibitors of Beta-Amyloid Aggregation
10/16/2008US20080255111 (4'-{[2-(tert-Butoxycarbonyl)-3-hydroxy-4-(trifluoromethyl)benzyl]oxy}-1,1'-biphenyl-4-yl)acetic acid; vascular restenosis following angioplasty, endarterectomy, percutaneous transluminal coronary angioplasty (PTCA) or stent implantation, blood coagulation diseases
10/16/2008US20080251169 Ionic liquid, a method of synthesizing an ionic liquid, a precursor of an explosive composition including at least one ionic liquid, and a method of desensitizing an explosive composition
10/16/2008CA2684747A1 Salts of isophosphoramide mustard and analogs thereof
10/15/2008EP1979307A1 Neutral labeling reactants and conjugates derived thereof
10/15/2008EP1978971A2 Arginine heteromers for topical administration
10/15/2008EP1628656B1 Gabapentin tannate in liquid and/or semi-solid dosage forms
10/15/2008EP1308436B1 Calcium receptor antagonists
10/15/2008EP0923544B1 Method for the synthesis of amines and amino acids with organoboron derivatives
10/15/2008CN101284865A New compound and its medicine use
10/15/2008CN101284796A Process for preparing DL-phenylalanine and DL-asparaginic acid by mother liquor reclamation
10/15/2008CN101284773A Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient
10/15/2008CN100425602C Diamine, acid dianhydride, polyimide composition having reactive group obtained therefrom, and processes for producing these
10/15/2008CN100425590C Propionyl-L-carnitine inner salt synthesis method
10/14/2008US7435845 Corrosion and gas hydrate inhibitors having improved water solubility and increased biodegradability
10/14/2008CA2457584C Enhancing solubility of iron amino acid chelates and iron proteinates
10/09/2008US20080249333 Reacting an amine with acrylic acid; secondary amine acts as scavenger for unreacted acrylic acid
10/09/2008US20080249329 Using strong acid and dialkyl carbonate; chemical intermeduiate for antibiotics
10/09/2008US20080249318 Splitting of the corresponding phenylindole compound containing lactam group; cyclooxygenase inhibitor
10/09/2008US20080249177 Selective beta 3-adrenoceptor stimulants; obesity, diabetes mellitus, hyperlipidemia, pollakiuria, urinary incontinence, intestinal hypermotility; e.g. 4'-{2-[(1S,2R)-2-hydroxy-2-(4-hydroxyphenyl)-1-methyl ethylamino]ethoxy}-2,3',5'-trimethylbiphenyl-4-carboxylic acid
10/09/2008US20080249175 N-Phenyloxamide derivatives
10/09/2008US20080249107 Comprising trihydroxy phenyl subunits; selectin inhibitors; side effect reduction; 3-{3-[3-(3,4,5-Trihydroxy-phenyl)-propionylamino]-phenylamino}-benzoic acid
10/09/2008US20080249031 Of (3S)-3-[N (N'-(2-tert-butylphenyl)oxamyl)alaninyl]amino-5-(2',3',5',6'-tetrafluorophenoxy)-4-oxopentanoic acid; liver fibrosis
10/09/2008US20080249030 Age Inhibitors
10/09/2008US20080248012 Modulator of adenosine triphosphate release from red blood cells; treating and preventing ischemic reperfusion injuries, cardiovascular and vasodilatory diseases
10/08/2008EP1977744A1 Polymorphic Form alpha of (S)-Pregabalin and process for its preparation
10/08/2008CN101282924A Chiral 3-carbamoylmethyl-5-methyl hexanoic acids, key intermediates for the new synthesis of (S)-pregabalin
10/08/2008CN101282764A Cosmetic composition comprising at least one fatty-chain polylysine, which is intended to improve the surface state of keratin fibres
10/08/2008CN101279983A 抗肿瘤联合药物 Joint anti-tumor drugs
10/08/2008CN100423721C Thrombopoietin mimetics
10/07/2008US7432388 Disubstituted chalcone oximes having RARγ retinoid receptor antagonist activity
10/07/2008US7432383 Intermediates for the hemisynthesis of taxanes and preparation processes therefor
10/07/2008US7432239 Polyoxyalkylene compound and method for making
10/07/2008US7432228 Applying a N-aryl(methyl)-p-hydroxy- or p-alkoxy--phenylalkylamine, e.g., 4-[2-(2-hydroxy-benzylamino)-ethyl]-phenol to inhibit 9-cis-epoxycarotenoid dioxygenase; plant growth regulators
10/07/2008US7432087 Beginning with diastereo-and enantioselective reduction of a keto ester to obtain the hydroxy ester; use in drug preparation
10/07/2008CA2445293C Labelled .gamma.-cyano-.alpha.-aminobutyric acid compounds
10/02/2008WO2008119028A1 Alkenyldiarylmethanes having nitrogen-containing carboxylic acid derivatives
10/02/2008WO2008118494A2 Fluoroalkyl surfactants
10/02/2008WO2008117305A2 A novel process for preparing pregabalin and its acid addition salts
10/02/2008WO2008067981A3 Whole-cell catalytic system comprising a hydantoinase, a racemase and a carbamoylase
10/02/2008CA2678771A1 Fluoroalkyl surfactants
10/01/2008EP1973867A1 Preparation of gamma-amino acids having affinity for the alpha-2-delta protein
10/01/2008EP1460994B1 Compounds for a controlled release of active molecules
10/01/2008CN101277927A Process for esterification of an organic acid
10/01/2008CN101277921A Carrier for separation, method for separation of compound, and method for synthesis of peptide using the carrier
10/01/2008CN101274926A Fluoro-and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof
10/01/2008CN101274900A 2-hydroxy halogeno-benzyl amino acid compound, preparation therefor and application thereof
10/01/2008CN101274899A Purification desalination process in L-carnitine production by electrodialysis
10/01/2008CN100422141C Method for producing 2-dihaloacyl-3-amino-acrylic acid esters and 3-dihalomethyl-pyrazole-4-carboxylic acid esters
09/2008
09/30/2008USRE40525 Hepatitis C inhibitor tri-peptides
09/30/2008US7429677 3'-methylene-bis(6-((4-methylphenyl)sulfonylamino)-benzoic acid) , or its N-oxide form, salt, stereoisomeric form, racemic mixture, prodrug or ester; block HIV from entering the human cell by interfering with various phases of attachment and fusion between HIV and the cell; Anti HIV agent; AIDS
09/30/2008US7429674 Alkylating an imine containing acid or ester group and two phenyl rings with a fluorotriflate electrophile to form a substituted imine, forming an azolactone, enzymetically opening the azolactone with a hydrolytic enzyme such as lipase B to form alkylamine, deprotecting alkylamide with an oxidizing agent
09/25/2008WO2008115920A2 Methods for the preparation and formulation of l-carnitine valproate salts
09/25/2008WO2008115149A1 N-HETEROCYCLIC CARBENE CATALYZED SYNTHESIS OF N-PHENYLISOXAZOLIDIN-5-ONE DERIVATIVE AND SYNTHESIS OF β -AMINO ACID ESTER DERIVATIVE
09/25/2008WO2008114506A1 Method for producing 4-aminomethylbenzoic acid
09/25/2008US20080234381 1-Hydroxy-naphthalene-2-carboxylic acid(4-cyano-2-trifluoromethoxy-phenyl)-amide; obesity, atherosclerosis, hypertension, type 2 diabetes, dyslipidemia, coronary heart disease, osteoarthritis, gallbladder disease, endometrial cancer, breast cancer, prostate cancer, colon cancer,
09/25/2008US20080234378 Methods for the preparation and formulation of l-carnitine valproate salts
09/25/2008US20080234372 Nutrient, foods; dietary supplements, energy drinks, and dietetic or pharmaceutical products; creatine glycinate
09/25/2008US20080234370 Calcilytic Compounds
09/25/2008US20080234281 2,3-Dihydrooxadiazoles such as 3-acetyl-5-(2,5-difluorophenyl)-2-phenyl-2,3-dihydro-1,3,4-oxadiazole and 3-[3-acetyl-5-(2,5-difluorophenyl)-2-phenyl-2,3-dihydro-1,3,4-oxadiazol-2-yl]-N,N-dimethylpropan-1-amine that are useful for treating cancer
09/25/2008US20080234202 Reacting carboxylic acid or amide derivative with amine compound to obtain amino acid analogs, peptides containing analogs of basic amino acids lysine and arginine; desamino amino acid compound, of the extended or truncated peptide; pain, psychosis, obesity; cosmetics
09/24/2008CN101270061A Method for preparing collagen sugar
09/23/2008US7427692 Process for preparation of 7-[α-amino (4-hydroxyphenyl) acetamido]-3-substituted-3-cephem-4-carboxylic acid
09/23/2008US7427600 mesalamine covalently attached to carrier peptide at C-terminus, interspersed and/or side chain; releasing into bloodstream; reducing dosage
09/18/2008WO2008110529A1 Process for the preparation of amino acid methyl esters
09/18/2008WO2008110527A1 Process for the preparation of beta-lactam compounds
09/18/2008US20080227976 Process for producing chirally enriched aspartic and glutamic acid derivatives by subjecting a diazoketone derivative to conditions that effect rearrangement to form the corresponding homologation product; useful for preparing compounds that are caspase inhibitors
09/18/2008US20080227961 Chelation compounds, radionuclides
09/18/2008US20080227859 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
09/18/2008US20080227857 N-Alkylcarbonyl-Amino Acid Ester and N-Alkylcarbonyl-Amino Lactone Compounds and Their Use
09/17/2008CN101268037A Novel asymmetric synthesis of (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid
09/17/2008CN101268036A Process for producing 5-aminolevulinic acid hydrochloride
09/17/2008CN101265226A Compounds and methods for delivery of prostacyclin analogs
09/17/2008CN101265209A Method for extracting glutamic acid
09/17/2008CN101265178A Amino acid salt of (S)-ibuprofen and medicinal composition thereof
09/16/2008US7425648 Process for the preparation of nateglinide, preferably in B-form
09/16/2008US7425645 Ester-linked gemini surfactant compounds for use in gene therapy
1 ... 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 ... 215